BioNTech SE (BNTX) Gains from Sales and Divestitures (2019 - 2026)
BioNTech SE (BNTX) reported Gains from Sales and Divestitures of -$1.05 million for Q2 2026, compared with -$339,588 a year earlier.
Powered by 
Analysis
BioNTech SE (BNTX) Gains from Sales and Divestitures (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, BioNTech SE's Gains from Sales and Divestitures came in at -$3.61 million; for FY2025, it was -$2.91 million.
- By year, Gains from Sales and Divestitures came in at -$320,579 in FY2024, $4.09 million in FY2023 (+567.9%), $612,148 in FY2022 (-88.4%) and $5.26 million in FY2021 (+668.1%).
- Five-year quarterly Gains from Sales and Divestitures spans a low of -$1.52 million in Q3 2025 and a high of $4.8 million in Q4 2021.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$117,075 (Q1 2026), -$931,235 (Q4 2025) and -$1.52 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | BioNTech SE | 24.50 Bn | -34.86 Bn | 10.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.05 Mn |
| Mar 31, 2026 | -117,074.57 |
| Dec 31, 2025 | -931,234.81 |
| Sep 30, 2025 | -1.52 Mn |
| Jun 30, 2025 | -339,587.91 |
| Mar 31, 2025 | -105,188.44 |
| Dec 31, 2024 | -106,859.54 |
| Jun 30, 2024 | -215,377.52 |
| Dec 31, 2023 | 215,187.98 |
| Sep 30, 2023 | 3.59 Mn |
| Jun 30, 2023 | 108,892.44 |
| Mar 31, 2023 | 214,668.36 |
| Dec 31, 2022 | 204,049.47 |
| Sep 30, 2022 | 201,654.87 |
| Jun 30, 2022 | 213,411.34 |
| Dec 31, 2021 | 4.80 Mn |
| Sep 30, 2021 | 471,714.93 |
| Jun 30, 2021 | 240,854.29 |
| Mar 31, 2021 | 241,247.22 |
| Dec 31, 2020 | -119,228.98 |
API Access
BioNTech SE Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=BNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();